Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

356

Short-course antibiotic strategies for ventilator-associated pneumonia

Wei Cong Tan1,2, Joan Quah3, Andrew Yunkai Li4,5

  • 1Division of Infectious Diseases, University Medicine Cluster, National University Hospital.

Current Opinion in Infectious Diseases
|February 13, 2025
PubMed
Abstract

Insights

Shorter antibiotic courses for ventilator-associated pneumonia (VAP) are effective and safe. This approach reduces antimicrobial resistance and adverse events, supporting antibiotic stewardship programs.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pharmacology

Background:

  • Ventilator-associated pneumonia (VAP) treatment duration is debated.
  • Balancing antimicrobial resistance and clinical outcomes is crucial due to high VAP mortality.

Purpose of the Study:

  • To evaluate the evidence for shorter antibiotic durations in VAP treatment.
  • To assess the impact of shortened antibiotic courses on mortality, recurrence, and adverse events.

Main Methods:

  • Review of recent studies on VAP antibiotic treatment duration.
  • Analysis of clinical response-individualized antibiotic strategies.
  • Consideration of pathogen type, including resistant strains.

Main Results:

  • Shorter antibiotic courses may be adequate for VAP treatment, irrespective of pathogens.
  • No increase in mortality or recurrence observed with shorter durations.
  • Reduced risk of adverse events, such as acute kidney injury, with shorter courses.

Conclusions:

  • Shortening antibiotic treatment for VAP is a viable strategy when guided by clinical response.
  • This approach aids in reducing costs and antimicrobial resistance.
  • Pragmatic antibiotic stewardship is essential for VAP management, especially with diagnostic challenges.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.6K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
288
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
117
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146